• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高通量透析膜可改善慢性血液透析患者的脂质状况。

High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients.

作者信息

Blankestijn P J, Vos P F, Rabelink T J, van Rijn H J, Jansen H, Koomans H A

机构信息

Department of Nephrology, University Hospital, Utrecht, The Netherlands.

出版信息

J Am Soc Nephrol. 1995 Mar;5(9):1703-8. doi: 10.1681/ASN.V591703.

DOI:10.1681/ASN.V591703
PMID:7780060
Abstract

In a controlled prospective trial, the effect of a switch from cellulose-based, low-flux dialysis membranes to polysulphone, high-flux membranes on lipid parameters was evaluated. Baseline values of lipid parameters were identical in the study group and the control group in which the dialysis membrane remained unchanged. After 6 wk, total triglyceride, very low-density lipoprotein (VLDL) triglyceride, and VLDL cholesterol decreased, respectively, 28 +/- 17 (P < 0.01), 38 +/- 17 (P < 0.01), and 24 +/- 21% (P < 0.05), and the proportion of total cholesterol that was high-density lipoprotein cholesterol increased from 15 +/- 5 to 18 +/- 5% (P < 0.05) in the high-flux polysulphone group, whereas these variables remained unchanged in the control group. Low-density lipoprotein and total cholesterol as well as Kt/V, protein catabolic rate, parathyroid hormone, albumin, and body weight did not change. No change in lipoprotein lipase activity was found. In a second study, the effects of a single hemodialysis session with high-flux polysulphone and low-flux, cellulose-based membranes on lipid parameters and lipolytic activity were compared in a cross-over fashion. Treatment with both membranes resulted in a significant decrease in plasma triglyceride, VLDL triglyceride, and VLDL cholesterol. Lipoprotein lipase activity increased during hemodialysis. Changes in lipid parameters and lipolytic activity were identical during the two treatments.

摘要

在一项对照前瞻性试验中,评估了从纤维素基低通量透析膜切换到聚砜高通量膜对脂质参数的影响。研究组和透析膜未改变的对照组的脂质参数基线值相同。6周后,高通量聚砜组的总甘油三酯、极低密度脂蛋白(VLDL)甘油三酯和VLDL胆固醇分别下降了28±17(P<0.01)、38±17(P<0.01)和24±21%(P<0.05),高密度脂蛋白胆固醇占总胆固醇的比例从15±5增加到18±5%(P<0.05),而对照组的这些变量保持不变。低密度脂蛋白、总胆固醇以及Kt/V、蛋白质分解代谢率、甲状旁腺激素、白蛋白和体重均未改变。未发现脂蛋白脂肪酶活性有变化。在第二项研究中,以交叉方式比较了单次使用高通量聚砜膜和低通量纤维素基膜进行血液透析对脂质参数和脂解活性的影响。两种膜治疗均导致血浆甘油三酯、VLDL甘油三酯和VLDL胆固醇显著降低。血液透析期间脂蛋白脂肪酶活性增加。两种治疗期间脂质参数和脂解活性的变化相同。

相似文献

1
High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients.高通量透析膜可改善慢性血液透析患者的脂质状况。
J Am Soc Nephrol. 1995 Mar;5(9):1703-8. doi: 10.1681/ASN.V591703.
2
Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients.透析通量和膜材料对血液透析患者血脂异常和炎症的影响。
Nephrol Dial Transplant. 2004 Oct;19(10):2570-5. doi: 10.1093/ndt/gfh415. Epub 2004 Jul 27.
3
Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients.不同透析膜对血液透析患者血脂和脂蛋白血清谱的影响。
Nephron. 1995;69(3):323-6. doi: 10.1159/000188479.
4
Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?合成改性纤维素:用于血液透析的合成膜替代品?
Biomaterials. 1997 Oct;18(19):1299-303. doi: 10.1016/s0142-9612(97)00062-8.
5
Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.膜通透性对炎症和动脉僵硬度的影响:一项随机试验。
Clin J Am Soc Nephrol. 2010 Apr;5(4):652-8. doi: 10.2215/CJN.05620809. Epub 2010 Mar 4.
6
Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers.从醋酸纤维素透析膜更换为聚砜透析膜对蛋白质氧化和炎症标志物的影响。
Clin Nephrol. 2004 Mar;61(3):198-206. doi: 10.5414/cnp61198.
7
Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins--a cross-over trial.两种低通量醋酸纤维素透析器对血浆脂质和脂蛋白的影响——一项交叉试验。
Nephrol Dial Transplant. 1998 Jun;13(6):1452-7. doi: 10.1093/ndt/13.6.1452.
8
Prospective randomized pilot study on the effects of two synthetic high-flux dialyzers on dialysis patient anemia.两种合成高通量透析器对透析患者贫血影响的前瞻性随机对照试验研究
Int J Artif Organs. 2012 May;35(5):346-51. doi: 10.5301/ijao.5000101.
9
Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids.高通量与低通量血液透析的随机试验:对同型半胱氨酸和脂质的影响
Nephrol Dial Transplant. 2000 Jul;15(7):1029-34. doi: 10.1093/ndt/15.7.1029.
10
[Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients].
Nihon Jinzo Gakkai Shi. 1999 Jan;41(1):1-7.

引用本文的文献

1
Dyslipidemia in patients with chronic kidney disease.慢性肾脏病患者的血脂异常。
Rev Endocr Metab Disord. 2017 Mar;18(1):29-40. doi: 10.1007/s11154-016-9402-z.
2
Hemodiafiltration and hemodialysis differently affect P wave duration and dispersion on the surface electrocardiogram.血液滤过和血液透析对体表心电图P波时限及离散度的影响不同。
Int Urol Nephrol. 2016 Feb;48(2):271-7. doi: 10.1007/s11255-015-1144-4. Epub 2015 Nov 11.
3
Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation.他汀类药物对等待肾移植的血液透析患者的生存益处。
Int J Angiol. 2015 Jun;24(2):105-12. doi: 10.1055/s-0035-1547373.
4
Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic function.血液透析和血液透析滤过对左心室舒张功能的调节作用不同。
BMC Nephrol. 2013 Apr 2;14:76. doi: 10.1186/1471-2369-14-76.
5
The lipid story in chronic kidney disease: a long story with a happy end?慢性肾脏病中的脂质故事:一个有美好结局的漫长故事?
Int Urol Nephrol. 2013 Oct;45(5):1273-87. doi: 10.1007/s11255-012-0296-8.
6
High-flux versus low-flux membranes for end-stage kidney disease.用于终末期肾病的高通量膜与低通量膜
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD005016. doi: 10.1002/14651858.CD005016.pub2.
7
Dyslipidemia associated with chronic kidney disease.与慢性肾脏病相关的血脂异常
Open Cardiovasc Med J. 2011;5:41-8. doi: 10.2174/1874192401105010041. Epub 2011 Feb 24.
8
Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.膜通透性对炎症和动脉僵硬度的影响:一项随机试验。
Clin J Am Soc Nephrol. 2010 Apr;5(4):652-8. doi: 10.2215/CJN.05620809. Epub 2010 Mar 4.
9
Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素及合成膜在终末期肾病患者血液透析中的应用
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD003234. doi: 10.1002/14651858.CD003234.pub2.
10
Effect of dialysis membranes on lipoprotein profile of serum in haemodialysed patients.透析膜对血液透析患者血清脂蛋白谱的影响。
Int Urol Nephrol. 1998;30(6):789-98. doi: 10.1007/BF02564868.